Patent ID: 8877158
Filing Date: 2014-11-04
Classification: A61K,A61P,C07K

Abstract:
1. A method for targeting a substance to a neovascular site, which comprises administering a recombinant gelatin to a subject, wherein the recombinant gelatin has the following (1) or (2): (1) the amino acid sequence shown in SEQ ID NO: 1; or (2) an amino acid sequence having 80% or more percent identity to the amino acid sequence shown in SEQ ID NO: 1 and having an action to accumulate in newly formed blood vessels, and wherein the recombinant gelatin is used in combination with a labeled probe, the labeled probe being selected from the group consisting of a fluorescent dye, a radioisotope, a nuclide used for PET, a nuclide used for SPECT, an MRI contrast medium, a CT contrast medium, and a magnetic material.